Intrapartum Management of the Second Twin
Fadi Bsat, MD; Andrew Healy, MD;
Glenn Markenson, MD
Hyperemesis
in Pregnancy
Calla M. Holmgren, MD
Hyperemesis gravidarum—characterized by persistent nausea and vomiting,
in contrast to more commonly-occuring "morning sickness"—affects
0.3% to 2% of gravid women. It may lead to dehydration and other maternal
and/or fetal risks. This article addresses the prevalence, risks, and diagnosis
of hyperemesis, and proposes treatment strategies.
Botulinum Toxin for Restoration of Bladder Control
Richard M. Kostrzewa, PhD;
Rose Anna Kostrzewa, BS;
John P. Kostrzewa, MD
For patients with overactive bladder who cannot tolerate anticholingerics and/or are reluctant or poor surgical candidates, botulinum neurotoxin A (BoNT-A) may be a welcome alternative. This article describes the mechanism behind BoNT-A and reviews its potential medical applications. |
